StemEdit Gene Edited iPSCs

Brand: StemEdit by Stemgent® (REPROCELL®)

High-quality HLA knockout iPSC lines were developed using our state-of-the-art genome editing technology, utilizing an AI-enhanced nuclease system. This editing system is also well-suited for clinical gene-editing projects.

NOTE: These iPSC cell lines are developed and supplied for Research Use Only (RUO). They are not intended for clinical or therapeutic applications. However, this clone has a clinical-grade counterpart available that is suitable for clinical gene editing and downstream clinical development. If you require material for translational or clinical programs, please see Clinical Stem Cell Services or Contact Us for more information.

See also our complete collection of Research Use Only StemRNA™ Induced Pluripotent Stem Cells (iPSCs).

NEW OFFER: the clinical parental control iPSC line—used to develop our StemEdit™ hypoimmune iPSC lines—is now available in an affordable bundle with these gene-edited clones.

Interested? Reach out directly at info-us@reprocellusa.com for details.

Products: